Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?

To: MissLil who wrote (116)	3/5/1998 10:49:00 PM
From: BigKNY3	Respond to of 1016

Miss Lil: I own several Big Pharma stocks and am never concerned about refill rates, the production plant, producing product at risk from an unapproved plant or an ad recall by the FDA. This is a real weakness of VVUS..... It's total dependence on one product in a changing market place. Moreover, a clear sign of VVUS problems is that the VVUSers' spin "doctors" are in hiding.. VVUS may still have a future and could make some money for investors. However, it is clear this stock is risky and volatile...even if any good news is announced. Good investing! BigKNY3